Clinical Findings in General Paresis

General Paresis Clinical Trial

Official title:

Xijing HOSPITAL, Fourth Military Medical University, China

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00921648
• Other study ID #: 20080301
• Status: Completed
• Phase: N/A
• First received: October 21, 2008
• Last updated: June 15, 2009
• Start date: April 2008
• Est. completion date: January 2009

Study information

• Verified date: June 2009
• Source: Xijing Hospital
• Contact: n/a
• Is FDA regulated: No
• Health authority: China: Food and Drug Administration
• Study type: Observational

Clinical Trial Summary

This is a study of the clinical and neuroimaging of general paresis. The investigators studied six patients with general paresis.

Description:

Inclusion Criteria:

• Mental disorders

• positive TPHA in CSF and sera

• HIV-negative serology by ELISA

Exclusion Criteria:

• Negative TPHA in CSF and sera

• No image data

Recruitment information / eligibility

• Status: Completed
• Enrollment: 6
• Est. completion date: January 2009
• Est. primary completion date: December 2008
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 30 Years to 60 Years

Eligibility

Inclusion Criteria:

• EEG MR

Exclusion Criteria:

• Serological test

Study Design

Observational Model: Case-Only, Time Perspective: Retrospective

Related Conditions & MeSH terms

• General Paresis
• Muscle Weakness
• Neurosyphilis
• Paresis

Locations

Country	Name	City	State
China	Xijing Hospital	Xi'an	Shaanxi

Sponsors (1)

Lead Sponsor	Collaborator
Xijing Hospital

Country where clinical trial is conducted

China,